Results 281 to 290 of about 22,374,088 (435)

Outcomes associated with fetal nuchal translucency between 3.0 and 3.4 mm in the first trimester

open access: yesActa Obstetricia et Gynecologica Scandinavica, Volume 104, Issue 4, Page 629-636, April 2025.
Fetuses with nuchal translucency between 3.0 and 3.4 mm have high rates of chromosomal aberrations, highlighting the importance of prenatal screening. Our findings support proposing routine invasive testing for fetuses with nuchal translucency between 3.0 and 3.4 mm.
Manon D. E. Vriendt   +8 more
wiley   +1 more source

Cytogenetic Analysis of the Products of Conception After Spontaneous Abortion in the First Trimester.

open access: yesCytogenet Genome Res, 2021
Zhang X   +8 more
europepmc   +1 more source

Cytogenetic and molecular analysis of the acute monocytic leukemia cell line THP‐1 with an MLLAF9 translocation [PDF]

open access: green, 2000
María D. Odero   +3 more
openalex   +1 more source

A critical review of management of allogeneic transplant‐eligible adults with Ph+ acute lymphoblastic leukaemia

open access: yesBritish Journal of Haematology, EarlyView.
Proposed management of newly diagnosed Philadelphia chromosome‐positive (Ph+) acute lymphoblastic leukaemia (ALL) in transplant‐eligible patients. Suggested considerations when deciding the treatment pathway available to a newly diagnosed Ph+ ALL patient that would be deemed transplant eligible. Summary Acute lymphoblastic leukaemia (ALL) in 20%–30% of
Naranie Shanmuganathan, Andrew Grigg
wiley   +1 more source

Molecular Cytogenetic Analysis in Freshwater Prawns of the Genus Macrobrachium (Crustacea: Decapoda: Palaemonidae). [PDF]

open access: yesInt J Mol Sci, 2020
Molina WF   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy